I agree that this site is using cookies. You can find further informations here.
X
Abdelraouf, Kamilia
93  results:
Search for persons X
?
1

Defining optimal sulbactam regimens for treatment of Acinet..:

Abouelhassan, Yasmeen ; Nicolau, David P ; Abdelraouf, Kamilia
Journal of Antimicrobial Chemotherapy.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Ampicillin-sulbactam against Acinetobacter baumannii infect..:

Abouelhassan, Yasmeen ; Kuti, Joseph L ; Nicolau, David P.
Journal of Antimicrobial Chemotherapy.  , 2024
Link: https://doi.org/10.1093/..
 
?
3

Deciphering the Efficacy of β-Lactams in the Face of Metall..:

Abdelraouf, Kamilia ; Gill, Christian M ; Gethers, Matthew...
Open Forum Infectious Diseases.  11 (2024)  5 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
4

Imipenem/funobactam (formerly XNW4107) in vivo pharmacodyna..:

Fratoni, Andrew J ; Berry, Angela V ; Liu, Xiao...
Journal of Antimicrobial Chemotherapy.  78 (2023)  9 - p. 2343-2353 , 2023
Link: https://doi.org/10.1093/..
 
?
5

In vivopharmacokinetic/pharmacodynamic evaluation of cefepi..:

Abdelraouf, Kamilia ; Nicolau, David P
Journal of Antimicrobial Chemotherapy.  78 (2023)  3 - p. 692-702 , 2023
Link: https://doi.org/10.1093/..
 
?
6

In vivo efficacy of WCK 6777 (ertapenem/zidebactam) against..:

Gethers, Matthew ; Chen, Iris ; Abdelraouf, Kamilia.
Journal of Antimicrobial Chemotherapy.  77 (2022)  7 - p. 1931-1937 , 2022
Link: https://doi.org/10.1093/..
 
?
7

Assessment of sustained efficacy and resistance emergence u..:

Gill, Christian M. ; Abdelraouf, Kamilia ; Oota, Merime...
JAC-Antimicrobial Resistance.  4 (2022)  3 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
8

1652. Sulbactam against Acinetobacter baumannii Pneumonia: ..:

Abouelhassan, Yasmeen ; Kuti, Joseph L ; Nicolau, David P.
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
9

1722. In vivo Activity of Imipenem/XNW4107 Human-Simulated ..:

Fratoni, Andrew J ; Berry, Angela ; Yuan, Haitao...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
10

Murine Model for Measuring Effects of Humanized-Dosing of A..:

Leopold, Shana R. ; Abdelraouf, Kamilia ; Nicolau, David P....
Frontiers in Microbiology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
11

1650. Efficacy of β-Lactam Therapy against Infections Cause..:

Abdelraouf, Kamilia ; Gill, Christian M ; Gethers, Matthew...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
12

Comment on: An update on cefepime and its future role in co..:

Nicolau, David P ; Bhagwat, Sachin S ; Abdelraouf, Kamilia
Journal of Antimicrobial Chemotherapy.  76 (2021)  12 - p. 3326-3327 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Discrepancy in sustained efficacy and resistance emergence ..:

Gill, Christian M ; Abdelraouf, Kamilia ; Oota, Merime...
Journal of Antimicrobial Chemotherapy.  76 (2021)  10 - p. 2615-2621 , 2021
Link: https://doi.org/10.1093/..
 
?
14

In vivo activity of WCK 4282 (high-dose cefepime/tazobactam..:

Gill, Christian M ; Abdelraouf, Kamilia ; Nicolau, David P
Journal of Antimicrobial Chemotherapy.  76 (2021)  4 - p. 993-1000 , 2021
Link: https://doi.org/10.1093/..
 
?
15

Comparative in vivo activity of human-simulated plasma and ..:

Lasko, Maxwell J. ; Abdelraouf, Kamilia ; Nicolau, David P.
Journal of Antimicrobial Chemotherapy.  76 (2021)  9 - p. 2310-2316 , 2021
Link: https://doi.org/10.1093/..
 
1-15